These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 32835079)

  • 1. A SARS-CoV-2 vaccine candidate:
    Bhattacharya M; Sharma AR; Patra P; Ghosh P; Sharma G; Patra BC; Saha RP; Lee SS; Chakraborty C
    Inform Med Unlocked; 2020; 20():100394. PubMed ID: 32835079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of vaccine candidate against Omicron variant of SARS-CoV-2 using immunoinformatic approaches.
    Aasim ; Sharma R; Patil CR; Kumar A; Sharma K
    In Silico Pharmacol; 2022; 10(1):12. PubMed ID: 35898574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction and identification of T cell epitopes of COVID-19 with balanced cytokine response for the development of peptide based vaccines.
    Medha ; Bhatt P; Priyanka ; Sharma M; Sharma S
    In Silico Pharmacol; 2021; 9(1):40. PubMed ID: 34221846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine Design from the Ensemble of Surface Glycoprotein Epitopes of SARS-CoV-2: An Immunoinformatics Approach.
    Rahman N; Ali F; Basharat Z; Shehroz M; Khan MK; Jeandet P; Nepovimova E; Kuca K; Khan H
    Vaccines (Basel); 2020 Jul; 8(3):. PubMed ID: 32731461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoinformatics and molecular modeling approach to design universal multi-epitope vaccine for SARS-CoV-2.
    Khan MT; Islam MJ; Parihar A; Islam R; Jerin TJ; Dhote R; Ali MA; Laura FK; Halim MA
    Inform Med Unlocked; 2021; 24():100578. PubMed ID: 33898733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Next-Generation Vaccine Candidate Using Alternative Epitopes to Protect against Wuhan and All Significant Mutant Variants of SARS-CoV-2: An Immunoinformatics Approach.
    Bhattacharya M; Sharma AR; Ghosh P; Lee SS; Chakraborty C
    Aging Dis; 2021 Dec; 12(8):2173-2195. PubMed ID: 34881093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Scalable Topical Vectored Vaccine Candidate against SARS-CoV-2.
    Rohaim MA; Munir M
    Vaccines (Basel); 2020 Aug; 8(3):. PubMed ID: 32846910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An in-silico approach to develop of a multi-epitope vaccine candidate against SARS-CoV-2 envelope (E) protein.
    Ghafouri F; Cohan RA; Noorbakhsh F; Samimi H; Haghpanah V
    Res Sq; 2020 May; ():. PubMed ID: 32702713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering a novel subunit vaccine against SARS-CoV-2 by exploring immunoinformatics approach.
    Sarkar B; Ullah MA; Araf Y; Rahman MS
    Inform Med Unlocked; 2020; 21():100478. PubMed ID: 33200088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newcastle Disease Virus as a Vaccine Vector for SARS-CoV-2.
    Shirvani E; Samal SK
    Pathogens; 2020 Jul; 9(8):. PubMed ID: 32751194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CoronaVR: A Computational Resource and Analysis of Epitopes and Therapeutics for Severe Acute Respiratory Syndrome Coronavirus-2.
    Gupta AK; Khan MS; Choudhury S; Mukhopadhyay A; Sakshi ; Rastogi A; Thakur A; Kumari P; Kaur M; Shalu ; Saini C; Sapehia V; Barkha ; Patel PK; Bhamare KT; Kumar M
    Front Microbiol; 2020; 11():1858. PubMed ID: 32849449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-guided design of multi-epitopes vaccine against variants of concern (VOCs) of SARS-CoV-2 and validation through In silico cloning and immune simulations.
    Humayun F; Cai Y; Khan A; Farhan SA; Khan F; Rana UI; Qamar AB; Fawad N; Shamas S; Dongqing-Wei
    Comput Biol Med; 2022 Jan; 140():105122. PubMed ID: 34896886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Multi-Epitopic Peptide Vaccine Candidate Against
    Ghosh P; Bhakta S; Bhattacharya M; Sharma AR; Sharma G; Lee SS; Chakraborty C
    Int J Pept Res Ther; 2021; 27(2):1149-1166. PubMed ID: 33495694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A vaccine for SARS-CoV-2: goals and promises.
    EClinicalMedicine; 2020 Jul; 24():100494. PubMed ID: 32766547
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "Naringerin as candidate drug against SARS-CoV-2: The role for TPC2 genomic variants in COVID-19" [Pharmacol. Res. 164 (2021) 105402].
    Di Maria E; Martini P; Gennarelli M
    Pharmacol Res; 2021 Jun; 168():105597. PubMed ID: 33838999
    [No Abstract]   [Full Text] [Related]  

  • 16. [Strategies and current status of the race to develop a SARS-CoV-2 vaccine].
    Lanata De Las Casas CF; Gotuzzo Herencia E
    Rev Peru Med Exp Salud Publica; 2020 Dec; 37(3):401-402. PubMed ID: 33295540
    [No Abstract]   [Full Text] [Related]  

  • 17. Publisher Correction: A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions.
    Liu Y; Zhang X; Liu J; Xia H; Zou J; Muruato AE; Periasamy S; Kurhade C; Plante JA; Bopp NE; Kalveram B; Bukreyev A; Ren P; Wang T; Menachery VD; Plante KS; Xie X; Weaver SC; Shi PY
    Nat Commun; 2022 Oct; 13(1):6060. PubMed ID: 36229471
    [No Abstract]   [Full Text] [Related]  

  • 18. SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.
    N Engl J Med; 2021 Jun; 384(23):e92. PubMed ID: 34110115
    [No Abstract]   [Full Text] [Related]  

  • 19. Preclinical data from SARS-CoV-2 mRNA vaccine.
    Vabret N
    Nat Rev Immunol; 2020 Aug; 20(8):461. PubMed ID: 32572246
    [No Abstract]   [Full Text] [Related]  

  • 20. Inactivated vaccine for SARS-CoV-2.
    Risson E
    Nat Rev Immunol; 2020 Jun; 20(6):353. PubMed ID: 32355330
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.